XML 41 R29.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Discontinued Operations - (Details) - USD ($) shares in Thousands, $ in Millions |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended
--- | --- | --- | --- | --- | ---
Feb. 27, 2015 | Feb. 10, 2015 | Apr. 30, 2015 | Mar. 31, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015
After Tax Gain |  |  |  |  | $ (1) | $ 16 | $ 1,736
Gain on sale of Mylan shares |  |  |  |  |  |  | 207
Proceeds from the sale of Mylan shares |  |  |  |  |  |  | 2,290
Proceeds from the disposition of business |  |  |  |  |  | $ 25 | $ 230
Developed markets branded generics pharmaceuticals business |  |  |  |  |  |  |
Value of shares received for sale of generics pharmaceuticals business to Mylan Inc | $ 5,770 |  |  |  |  |  |
After Tax Gain | $ 1,600 |  |  |  |  |  |
Developed markets branded generics pharmaceuticals business | Minimum |  |  |  |  |  |  |
Period for providing manufacturing supply of products | 3 years |  |  |  |  |  |
Developed markets branded generics pharmaceuticals business | Maximum |  |  |  |  |  |  |
Period of transition services | 2 years |  |  |  |  |  |
Period for providing manufacturing supply of products | 10 years |  |  |  |  |  |
Period of notice require to terminate manufacturing supply of products | 2 years |  |  |  |  |  |
Animal Health Business |  |  |  |  |  |  |
After Tax Gain |  | $ 130 |  | $ 16 |  |  |
Proceeds from the disposition of business |  | $ 230 |  | $ 25 |  |  |
Mylan |  |  |  |  |  |  |
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc |  |  | 110,000 |  |  |  |
Number of shares in investment sold |  |  | 40,250 |  |  |  |
Gain on sale of Mylan shares |  |  |  |  | 207 |  |
Proceeds from the sale of Mylan shares |  |  |  |  | 2,290 |  |
Mylan | Developed markets branded generics pharmaceuticals business |  |  |  |  |  |  |
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc | 110,000 |  |  |  |  |  |
Percentage of shares received for sale of generics pharmaceuticals business to Mylan Inc | 22.00% |  |  |  |  |  |
Gain on sale of Mylan shares |  |  |  |  | 207 |  |
Proceeds from the sale of Mylan shares |  |  |  |  | $ 2,290 |  |
Mylan NV |  |  |  |  |  |  |
Ownership interest (as a percent) |  |  | 14.00% |  | 14.00% |  | 14.00%
Mylan NV | Developed markets branded generics pharmaceuticals business |  |  |  |  |  |  |
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc |  |  |  |  | 110,000 |  |
Number of shares in investment sold |  |  |  |  | 40,300 |  |

X
- Definition Represents the number of shares of new business to be received by the company from the buyer as the price for sale of a developed markets branded generics pharmaceuticals business. + References No definition available. + Details
Name: | abt_ConsiderationReceivedForSaleOfBusinessInShares
Namespace Prefix: | abt_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage of shares of new business will be received from Mylan as the price for sale of developed markets branded generics pharmaceuticals business. + References No definition available. + Details
Name: | abt_ConsiderationReceivedForSaleOfBusinessInSharesAsPercentage
Namespace Prefix: | abt_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the period for providing various back office support transition services as per agreement. + References No definition available. + Details
Name: | abt_PeriodForProvidingBackOfficeSupportTransitionServicesUnderAgreement
Namespace Prefix: | abt_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the period for providing certain manufacturing supply of products as per agreement. + References No definition available. + Details
Name: | abt_PeriodForProvidingManufacturingSupplyOfProductsUnderAgreement
Namespace Prefix: | abt_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the period of notice required to terminate agreement for providing certain manufacturing supply of products. + References No definition available. + Details
Name: | abt_PeriodOfNoticeRequiredToTerminateManufacturingSupplyOfProducts
Namespace Prefix: | abt_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents number of shares in investment is sold. + References No definition available. + Details
Name: | abt_SaleOfStockNumberOfSharesSold
Namespace Prefix: | abt_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3B -URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5C -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759 + Details
Name: | us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation. + References No definition available. + Details
Name: | us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.13(h)) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 + Details
Name: | us-gaap_GainLossOnSaleOfEquityInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 + Details
Name: | us-gaap_ProceedsFromDivestitureOfBusinesses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 + Details
Name: | us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_DisposalGroupClassificationAxis=abt_DevelopedMarketsBrandedGenericsPharmaceuticalsBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DisposalGroupClassificationAxis=abt_AnimalHealthBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=abt_MylanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=abt_MyLanNVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |